AI assistant
Sending…
Roivant Sciences Ltd. — Director's Dealing 2019
Nov 27, 2019
30587_dirs_2019-11-27_d798fb33-cb17-4c66-bce4-2ba28cda0018.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Myovant Sciences Ltd. (MYOV)
CIK: 0001679082
Period of Report: 2019-11-25
Reporting Person: Roivant Sciences Ltd. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-25 | Common Shares, par value $0.000017727 per share | P | 3500000 | $15.00 | Acquired | 44509411 | Direct |
Footnotes
F1: On November 25, 2019, the Reporting Person entered into a stock purchase agreement with a third party pursuant to which the Reporting Person agreed to purchase an aggregate of 3,500,000 Common Shares from such third party for a purchase price equal to $15.00 per Common Share. The stock purchase agreement provides that these Common Shares will be delivered to the Reporting Person within 10 calendar days following execution of the stock purchase agreement (or a later date as mutually agreed by the parties).
More from Roivant Sciences Ltd.
Registration Form
2026
May 20
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 18